United States: Texas Court Enjoins Enforcement Of Regulation That Would Forbid Discrimination In Healthcare On The Basis Of Gender Identity And Termination Of Pregnancy

Executive Summary: As LGBTQ rights have taken center stage in political and social issues, FordHarrison has been following ground-breaking litigation related to LGBTQ rights and providing updates. In the latest decision, a federal judge in Texas instituted a nationwide preliminary injunction against the enforcement of a regulation promulgated by the United States Department of Health and Human Services (HHS) under the authority of Section 1557 of the Patient Protection and Affordable Care Act (ACA) that the plaintiffs argued would have required health care providers to perform, and health insurance companies to cover, gender transition procedures and abortion effective January 1, 2017. See Franciscan Alliance v. Burwell (December 31, 2016).

Background: The ACA, also known as "Obamacare," was passed on March 23, 2010. Its provisions were to be rolled out and implemented over the next 10 years. While it is most famously known for mandating health care insurance coverage and providing subsidies for those individuals whose income falls under certain thresholds, it also provides various protections. One of these prohibits discrimination by any "health program or activity which is receiving Federal financial assistance" on the basis of, among other things, sex (Section 1557). Federal financial assistance includes grants and Medicare and Medicaid  payments, so entities covered by the Rule include hospitals, medical practices, nursing homes, health insurers, and self-funded employer health plans that receive federal payments, like Medicare Part D subsidies. A self-funded employer plan that does not receive any federal financial assistance is not subject to the Rule, but a third-party administrator that is subject to the Rule as an insurer or otherwise would be subject to the Rule in administering the employer's self-funded plan, and the sponsoring employer would be subject to other applicable nondiscrimination laws with respect to the plan's design.

Section 1557 incorporates the definition of sex from Title IX of the Education Amendments Act of 1972. For over 40 years, courts consistently have viewed the prohibition against sex discrimination in Title IX as related solely to the physiological differences between individuals' gender assigned at birth. Recently, efforts have been made to expand the interpretation of this definition to also include gender identity and sexual orientation; however, the issue remains outstanding and undecided.  

The effort to expand the definition of sex in Title IX was again brought to the forefront when HHS issued its Final Rule implementing Section 1557 on May 16, 2016. Pursuant to the Final Rule, health insurance companies and other healthcare facilities were provided until January 1, 2017, to make any necessary changes to coverage and services offered to comply with, among other things, the "sex" nondiscrimination provision in Subpart B. The Rule's definition of sex explicitly includes "gender identity" and "termination of pregnancy." Therefore, the Rule overtly prohibits discrimination in health care services on the basis of gender identity and pregnancy termination. It prevents providers and insurers from categorically refusing to provide or cover gender transition treatments and procedures, regardless of whether formerly considered "cosmetic," and treatments for gender dysphoria, irrespective of age. The plaintiffs in Franciscan Alliance also argued that the Rule could be used to require covered entities to perform or provide coverage for abortion. Unlike Title IX, however, the Rule does not include a religious exemption allowing institutions to opt out of provisions contrary to their closely held religious beliefs. The plaintiffs challenged the Rule's definition of sex, arguing that it requires physicians to provide healthcare to patients in violation of their religion and contrary to their best medical judgment and that it will require costly and burdensome health insurance changes.

The Decision: On December 31, 2016, just one day before the regulation would have gone into effect, the court granted a nationwide preliminary injunction, limited to the implementation of the Rule's "gender identity" and "termination of pregnancy" provisions.

First, the court held that the Rule violates the APA because it is contrary to law and exceeds statutory authority. Significantly, the court noted that Section 1557 unambiguously incorporates the meaning of sex as provided in Title IX. According to the court, in enacting Title IX, Congress did not intend to include gender identity in the definition of "sex." Likewise, the court reasoned that had Congress wanted to include gender identity in the definition of "sex" in the ACA, it would have included it specifically in Section 1557, knowing that Title IX's definition of sex did not include gender identity. Moreover, the court noted that when the ACA was passed in 2010, the common usage of sex did not include gender identity.

The court also focused on the fact that Title IX includes a religious exemption, which the Rule flatly ignores. The court relied on Congress's citation to Title IX as "20 U.S.C. § 1681, et seq.," as evidence of its intent to incorporate all of Title IX into the ACA, including the religious exemption. The Rule's failure to so, the court reasoned, renders the Rule contrary to law.

Second, the court held that the Rule likely violates the Religious Freedom Restoration Act (RFRA) with respect to the three religious private healthcare provider plaintiffs. The RFRA provides that the "[g]overnment may substantially burden a person's exercise of religion only if it demonstrates that application of the burden to the person is the least restrictive means of furthering [a] compelling government interest." For the RFRA to apply, there must be a sincere religious belief or exercise that has been substantially burdened by government action. In this case, the court found that the Rule, as written, "places substantial pressure on [them] to perform and cover transition and abortion procedures." Because the religious organizations associated with the three healthcare providers have long-held religious beliefs that gender transition and abortion are "immoral" and "evil," the court doubted that there was a "compelling interest" that would permit such a restriction on religious beliefs.

Of note, the court asserted that the government's various programs for providing health insurance did not mandate coverage for gender transition, which belied the existence of a compelling interest. The court noted that neither Medicare nor Medicaid mandates such coverage and that TRICARE specifically excludes transition surgeries. The court also cited an HHS report indicating that there was insufficient evidence to determine whether gender reassignment surgery would be effective for the Medicare population. Additionally, the court concluded that even if there was a compelling interest, this was not the least-restrictive means available. This reasoning is consistent with a Michigan federal court's ruling last year in EEOC v. R.G. & G.R. Harris Funeral Homes, where the defendant funeral home was granted summary judgment on the grounds that it was entitled to an RFRA exemption from Title VII – and the body of case law concerning sex stereotyping that has developed under it – based on the unique facts and circumstances of that case, which involved discrimination against a transgender employee and application of the employer's uniform policy.

What Does This Mean? LGBTQ and women's rights remain developing areas of the law. The law, especially in relation to LGBTQ rights, remains conflicted. The Franciscan Alliance analysis regarding the meaning of "sex" as used in Title IX could be derailed by the U.S. Supreme Court as it prepares to decide precisely that issue in Gloucester County School Board v. G.G. In that case, G.G., a transgender student, was denied access to the bathroom corresponding to his gender identity. The Fourth Circuit deferred to the Department of Education's interpretation of sex to include gender identity, and held that a claim alleging discrimination based on gender identity is a viable claim under Title IX. The U.S. Supreme Court has agreed to hear the case and briefing is currently taking place.

The definition of sex, as defined by Title VII, is also under examination by the Seventh Circuit in Hively v. Ivy Tech Community College, South Bend, the Eleventh Circuit in Evans v. Georgia Regional Hospital, and the Second Circuit in Christiansen v. Omnicom Group, Inc. and Carrigan v. Brietling USA, Inc. As reported in a previous Legal Alert, it appears likely that Hively will be decided soon, concluding that the definition of sex in Title VII does include sexual orientation. This decision may also influence how other courts interpret "sex" in other statutes, such as Section 1557 of the ACA and Title IX.

Additionally, practitioners, business owners and Human Resource specialists should be on the lookout for further RFRA challenges to similar government legislation and regulations, as well as Title VII claims. Healthcare providers and employers that sponsor self-insured health plans that receive federal subsidies (i.e., Medicare Part D subsidies) should also be aware that the outcome of this case may impact the coverage their health plans must provide for gender transition procedures, to the extent Section 1557 even survives ACA repeal efforts. Otherwise noncovered employers that sponsor insured health plans may see insurance policy gender transition coverage options change based on the outcome of this action.

As the injunction only applies to the Rule's "gender identity" and "termination of pregnancy" provisions, covered entities, including most healthcare providers and self-funded health plans that receive Medicare Part D subsidies, must continue to comply with other parts of the Rule, such as the requirement to provide language assistance to participants with limited English proficiency.

Bottom Line: In the employment context, this decision has several implications. First, the regulation itself will be influenced by President-Elect Trump's actions relating to the ACA when he takes office. Total repeal of the ACA or portions of it could make this preliminary injunction moot. Even if the ACA is not repealed, Trump's policies in the immediate aftermath of his election could influence whether this injunction becomes permanent. Second, employers with self-insured health plans subject to the Rule should watch this litigation closely to ensure compliance with the enjoined provisions if the injunction is removed. Healthcare facilities should also follow this litigation closely to ensure nondiscrimination in services provided. Finally, employers with insured plans may want to consult with their health insurance carriers and brokers to ensure that the plans they sponsor comply with the Rule and should keep an open line of communication with employees who may be concerned about health insurance coverage for gender transition related procedures.

Stay tuned for further updates on this rapidly developing area of the law.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.